Inflammatory Signaling Sensitizes Piezo1 Mechanotransduction in Articular Chondrocytes As a Pathogenic Feed-forward Mechanism in Osteoarthritis
Overview
Authors
Affiliations
Osteoarthritis (OA) is a painful and debilitating condition of synovial joints without any disease-modifying therapies [A. M. Valdes, T. D. Spector, 7, 23-32 (2011)]. We previously identified mechanosensitive PIEZO channels, PIEZO1 and PIEZO2, both expressed in articular cartilage, to function in chondrocyte mechanotransduction in response to injury [W. Lee , 111, E5114-E5122 (2014); W. Lee, F. Guilak, W. Liedtke, 79, 263-273 (2017)]. We therefore asked whether interleukin-1-mediated inflammatory signaling, as occurs in OA, influences iezo gene expression and channel function, thus indicative of maladaptive reprogramming that can be rationally targeted. Primary porcine chondrocyte culture and human osteoarthritic cartilage tissue were studied. We found that interleukin-1α (IL-1α) up-regulated Piezo1 in porcine chondrocytes. Piezo1 expression was significantly increased in human osteoarthritic cartilage. Increased Piezo1 expression in chondrocytes resulted in a feed-forward pathomechanism whereby increased function of Piezo1 induced excess intracellular Ca at baseline and in response to mechanical deformation. Elevated resting state Ca in turn rarefied the F-actin cytoskeleton and amplified mechanically induced deformation microtrauma. As intracellular substrates of this OA-related inflammatory pathomechanism, in porcine articular chondrocytes exposed to IL-1α, we discovered that enhanced Piezo1 expression depended on p38 MAP-kinase and transcription factors HNF4 and ATF2/CREBP1. CREBP1 directly bound to the proximal gene promoter. Taken together, these signaling and genetic reprogramming events represent a detrimental Ca-driven feed-forward mechanism that can be rationally targeted to stem the progression of OA.
Recent applications of stimulus-responsive smart hydrogels for osteoarthritis therapy.
Xu Z, Liu J, Hu H, Ma J, Yang H, Chen J Front Bioeng Biotechnol. 2025; 13:1539566.
PMID: 40035023 PMC: 11872905. DOI: 10.3389/fbioe.2025.1539566.
Emerging roles of Piezo1 channels in bone: Cells and diseases.
Zhang S, Li C, Feng Y, Lei W, Sun X Chin Med J (Engl). 2025; .
PMID: 39920897 PMC: 11882270. DOI: 10.1097/CM9.0000000000003483.
In Vitro Induction of Hypertrophic Chondrocyte Differentiation of Naïve MSCs by Strain.
Jorimann T, Fullemann P, Jose A, Matthys R, Wehrle E, Stoddart M Cells. 2025; 14(1.
PMID: 39791725 PMC: 11720650. DOI: 10.3390/cells14010025.
The Role of Mechanosensitive Piezo Channels in Chronic Pain.
Wan Y, Zhou J, Li H J Pain Res. 2024; 17:4199-4212.
PMID: 39679432 PMC: 11646438. DOI: 10.2147/JPR.S490459.
Piezo1: the key regulators in central nervous system diseases.
Xu Y, Wang Y, Yang Y, Fang X, Wu L, Hu J Front Cell Neurosci. 2024; 18:1441806.
PMID: 39539343 PMC: 11557416. DOI: 10.3389/fncel.2024.1441806.